ASCO Meeting Abstracts -- Paschka et al. 24 (18 Supplement): 2 Table 1

Endpoint	inv(16)		P-value	t(8;21)		P-value
Endpoint	Categories	HR^*	P-value	Categories	HR^*	P-value

CIR	mKIT vs wtKIT	2.08	.09	mKIT vs wtKIT	5.17	.004
	mKIT17 vs wtKIT	6.39	<.001	mKIT17 vs wtKIT	5.18	.005
OS	mKIT vs wtKIT	3.88	.009	mKIT vs wtKIT	1.80	.23
	mKIT17 vs wtKIT	3.25	.06	mKIT17 vs wtKIT	1.74	.29

^* HR, hazard ratio

% blasts in blood included in the multivariable model

Gender (male vs female) included in the multivariable model